Clinical Trials

Clinical trials are both a treatment option for all types of patients and the core way that new advances are made in AML care. Learn more about these clinical trials.

Recent Articles

The Effectiveness Of Voruciclib As A Monotherapy And In Combination With Venetoclax

October 17, 2023

Better tolerated and more effective therapies are needed for the treatment of AML.

Uproleselan Targets E-Selectin Biomarkers in AML

October 10, 2023

E-selectin is a biomarker that is currently being investigated for its efficacy in AML treatment.

Phase 3 Results Of Iomab-B Show Success For Transplanted AML

October 03, 2023

Recent findings from a Phase 3 study “resulted in the disappearance of all signs of cancer from treatment for six months."

What Are Clinical Trials And Why Consider One?

September 22, 2023

Explore the significance of clinical trials and their impact on an AML cure.

Nexavar (Sorafenib) Shows Relapse-Free Success When Used After Transplant

August 29, 2023

When treating AML, a stem cell transplant is generally the most successful treatment option.

ASCO 2023: A Vaccine Therapy in Development for AML

June 28, 2023

HealthTree spoke with Dr. Jamy at ASCO 2023 about his open clinical trial utilizing a new vaccine therapy for non-transplant eligible AML patients.

5 Important AML Clinical Trials And Their Current Status

June 15, 2023

Let's review 5 important clinical trials for patients with AML.

Results for Briquilimab, a Well Tolerated Conditioning Agent Used Before Transplant

June 06, 2023

Briquilimab has shown it is a safe and well-tolerated conditioning agent for older patients receiving an allogeneic hematopoietic cell transplantation.